The expression of two NEtD/NEPC lncRNA transcripts (SSTR5-AS1 and LINC00514) was able to separate patients more likely to develop metastatic disease from those that did not (P = 0.005 and P = 0.010, respectively; Fig. 6A). This evidence concerns the gene SSTR5 and metastatic neoplasm.